Qiagen NV (QGEN)
44.14
+0.10
(+0.23%)
USD |
NYSE |
Mar 18, 16:00
44.13
-0.01
(-0.02%)
Pre-Market: 20:00
Qiagen Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2022 | 2.142B |
September 30, 2022 | 2.226B |
June 30, 2022 | 2.261B |
March 31, 2022 | 2.313B |
December 31, 2021 | 2.252B |
September 30, 2021 | 2.240B |
June 30, 2021 | 2.190B |
March 31, 2021 | 2.065B |
December 31, 2020 | 1.870B |
September 30, 2020 | 1.713B |
June 30, 2020 | 1.612B |
March 31, 2020 | 1.550B |
December 31, 2019 | 1.526B |
September 30, 2019 | 1.516B |
June 30, 2019 | 1.511B |
March 31, 2019 | 1.507B |
December 31, 2018 | 1.502B |
September 30, 2018 | 1.496B |
June 30, 2018 | 1.482B |
March 31, 2018 | 1.453B |
December 31, 2017 | 1.418B |
September 30, 2017 | 1.387B |
June 30, 2017 | 1.362B |
March 31, 2017 | 1.347B |
December 31, 2016 | 1.338B |
Date | Value |
---|---|
September 30, 2016 | 1.320B |
June 30, 2016 | 1.296B |
March 31, 2016 | 1.281B |
December 31, 2015 | 1.281B |
September 30, 2015 | 1.293B |
June 30, 2015 | 1.315B |
March 31, 2015 | 1.326B |
December 31, 2014 | 1.345B |
September 30, 2014 | 1.345B |
June 30, 2014 | 1.331B |
March 31, 2014 | 1.315B |
December 31, 2013 | 1.302B |
September 30, 2013 | 1.287B |
June 30, 2013 | 1.270B |
March 31, 2013 | 1.262B |
December 31, 2012 | 1.254B |
September 30, 2012 | 1.242B |
June 30, 2012 | 1.227B |
March 31, 2012 | 1.202B |
December 31, 2011 | 1.170B |
September 30, 2011 | 1.121B |
June 30, 2011 | 1.107B |
March 31, 2011 | 1.087B |
December 31, 2010 | 1.087B |
September 30, 2010 | 1.090B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
1.507B
Minimum
Mar 2019
2.313B
Maximum
Mar 2022
1.906B
Average
1.968B
Median
Revenue (TTM) Benchmarks
MoonLake Immunotherapeutics | -- |
Thermo Fisher Scientific Inc | 42.86B |
uniQure NV | 15.84M |
ProQR Therapeutics NV | 7.046M |
Merus NV | 43.95M |